A small molecule Smac mimic potentiates TRAIL-mediated cell death of ovarian cancer cells

Eleonora Petrucci, Luca Pasquini, Alessia Petronelli, Ernestina Saulle, Gualtiero Mariani, Roberta Riccioni, Mauro Biffoni, Gianluigi Ferretti, Pieluigi Benedetti-Panici, Francesco Cognetti, Giovanni Scambia, Robin Humphreys, Cesare Peschle, Ugo Testa

Research output: Contribution to journalArticle

Abstract

Objectives.: Ovarian cancer remains a leading cause of death in women and development of new therapies is essential. Second mitochondria derived activator of caspase (Smac) has been described to sensitize for apoptosis. We have explored the proapoptotic activity of a small molecule mimic of Smac/DIABLO on ovarian cancer cell lines (A2780 cells and its chemoresistant derivatives A2780/ADR and A2780/DDP), cancer cell lines and in primary ovarian cancer cells. Methods.: The effects of a small molecule mimic of Smac/DIABLO on ovarian cancer cell lines and primary ovarian cancer cells were determined by cell proliferation, apoptosis and biochemical assays. Results.: This compound added alone elicited only a weak proapoptotic effect; however, it strongly synergizes with tumor necrosis factor-related apoptosis inducing ligand (TRAIL) or agonistic TRAILR2 antibody (Lexatumumab) in inducing apoptosis of ovarian cancer cells. Conclusions.: These observations suggest that small molecule mimic of Smac/DIABLO could be useful for the development of experimental strategies aiming to treat ovarian cancer. Interestingly, in addition to its well known proapoptotic effects, Smac/DIABLO elicited a significant increase of pro-caspase-3 levels.

Original languageEnglish
Pages (from-to)481-492
Number of pages12
JournalGynecologic Oncology
Volume105
Issue number2
DOIs
Publication statusPublished - May 2007

Fingerprint

Caspases
Ovarian Neoplasms
Mitochondria
Cell Death
Apoptosis
Cell Line
Caspase 3
Cause of Death
Tumor Necrosis Factor-alpha
Cell Proliferation
Ligands
Antibodies
Neoplasms

Keywords

  • Apoptosis
  • Ovarian cancer
  • Smac/DIABLO
  • TRAIL

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Oncology

Cite this

Petrucci, E., Pasquini, L., Petronelli, A., Saulle, E., Mariani, G., Riccioni, R., ... Testa, U. (2007). A small molecule Smac mimic potentiates TRAIL-mediated cell death of ovarian cancer cells. Gynecologic Oncology, 105(2), 481-492. https://doi.org/10.1016/j.ygyno.2007.01.011

A small molecule Smac mimic potentiates TRAIL-mediated cell death of ovarian cancer cells. / Petrucci, Eleonora; Pasquini, Luca; Petronelli, Alessia; Saulle, Ernestina; Mariani, Gualtiero; Riccioni, Roberta; Biffoni, Mauro; Ferretti, Gianluigi; Benedetti-Panici, Pieluigi; Cognetti, Francesco; Scambia, Giovanni; Humphreys, Robin; Peschle, Cesare; Testa, Ugo.

In: Gynecologic Oncology, Vol. 105, No. 2, 05.2007, p. 481-492.

Research output: Contribution to journalArticle

Petrucci, E, Pasquini, L, Petronelli, A, Saulle, E, Mariani, G, Riccioni, R, Biffoni, M, Ferretti, G, Benedetti-Panici, P, Cognetti, F, Scambia, G, Humphreys, R, Peschle, C & Testa, U 2007, 'A small molecule Smac mimic potentiates TRAIL-mediated cell death of ovarian cancer cells', Gynecologic Oncology, vol. 105, no. 2, pp. 481-492. https://doi.org/10.1016/j.ygyno.2007.01.011
Petrucci E, Pasquini L, Petronelli A, Saulle E, Mariani G, Riccioni R et al. A small molecule Smac mimic potentiates TRAIL-mediated cell death of ovarian cancer cells. Gynecologic Oncology. 2007 May;105(2):481-492. https://doi.org/10.1016/j.ygyno.2007.01.011
Petrucci, Eleonora ; Pasquini, Luca ; Petronelli, Alessia ; Saulle, Ernestina ; Mariani, Gualtiero ; Riccioni, Roberta ; Biffoni, Mauro ; Ferretti, Gianluigi ; Benedetti-Panici, Pieluigi ; Cognetti, Francesco ; Scambia, Giovanni ; Humphreys, Robin ; Peschle, Cesare ; Testa, Ugo. / A small molecule Smac mimic potentiates TRAIL-mediated cell death of ovarian cancer cells. In: Gynecologic Oncology. 2007 ; Vol. 105, No. 2. pp. 481-492.
@article{4df3cd578ef14abfbafd4025619f87bc,
title = "A small molecule Smac mimic potentiates TRAIL-mediated cell death of ovarian cancer cells",
abstract = "Objectives.: Ovarian cancer remains a leading cause of death in women and development of new therapies is essential. Second mitochondria derived activator of caspase (Smac) has been described to sensitize for apoptosis. We have explored the proapoptotic activity of a small molecule mimic of Smac/DIABLO on ovarian cancer cell lines (A2780 cells and its chemoresistant derivatives A2780/ADR and A2780/DDP), cancer cell lines and in primary ovarian cancer cells. Methods.: The effects of a small molecule mimic of Smac/DIABLO on ovarian cancer cell lines and primary ovarian cancer cells were determined by cell proliferation, apoptosis and biochemical assays. Results.: This compound added alone elicited only a weak proapoptotic effect; however, it strongly synergizes with tumor necrosis factor-related apoptosis inducing ligand (TRAIL) or agonistic TRAILR2 antibody (Lexatumumab) in inducing apoptosis of ovarian cancer cells. Conclusions.: These observations suggest that small molecule mimic of Smac/DIABLO could be useful for the development of experimental strategies aiming to treat ovarian cancer. Interestingly, in addition to its well known proapoptotic effects, Smac/DIABLO elicited a significant increase of pro-caspase-3 levels.",
keywords = "Apoptosis, Ovarian cancer, Smac/DIABLO, TRAIL",
author = "Eleonora Petrucci and Luca Pasquini and Alessia Petronelli and Ernestina Saulle and Gualtiero Mariani and Roberta Riccioni and Mauro Biffoni and Gianluigi Ferretti and Pieluigi Benedetti-Panici and Francesco Cognetti and Giovanni Scambia and Robin Humphreys and Cesare Peschle and Ugo Testa",
year = "2007",
month = "5",
doi = "10.1016/j.ygyno.2007.01.011",
language = "English",
volume = "105",
pages = "481--492",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - A small molecule Smac mimic potentiates TRAIL-mediated cell death of ovarian cancer cells

AU - Petrucci, Eleonora

AU - Pasquini, Luca

AU - Petronelli, Alessia

AU - Saulle, Ernestina

AU - Mariani, Gualtiero

AU - Riccioni, Roberta

AU - Biffoni, Mauro

AU - Ferretti, Gianluigi

AU - Benedetti-Panici, Pieluigi

AU - Cognetti, Francesco

AU - Scambia, Giovanni

AU - Humphreys, Robin

AU - Peschle, Cesare

AU - Testa, Ugo

PY - 2007/5

Y1 - 2007/5

N2 - Objectives.: Ovarian cancer remains a leading cause of death in women and development of new therapies is essential. Second mitochondria derived activator of caspase (Smac) has been described to sensitize for apoptosis. We have explored the proapoptotic activity of a small molecule mimic of Smac/DIABLO on ovarian cancer cell lines (A2780 cells and its chemoresistant derivatives A2780/ADR and A2780/DDP), cancer cell lines and in primary ovarian cancer cells. Methods.: The effects of a small molecule mimic of Smac/DIABLO on ovarian cancer cell lines and primary ovarian cancer cells were determined by cell proliferation, apoptosis and biochemical assays. Results.: This compound added alone elicited only a weak proapoptotic effect; however, it strongly synergizes with tumor necrosis factor-related apoptosis inducing ligand (TRAIL) or agonistic TRAILR2 antibody (Lexatumumab) in inducing apoptosis of ovarian cancer cells. Conclusions.: These observations suggest that small molecule mimic of Smac/DIABLO could be useful for the development of experimental strategies aiming to treat ovarian cancer. Interestingly, in addition to its well known proapoptotic effects, Smac/DIABLO elicited a significant increase of pro-caspase-3 levels.

AB - Objectives.: Ovarian cancer remains a leading cause of death in women and development of new therapies is essential. Second mitochondria derived activator of caspase (Smac) has been described to sensitize for apoptosis. We have explored the proapoptotic activity of a small molecule mimic of Smac/DIABLO on ovarian cancer cell lines (A2780 cells and its chemoresistant derivatives A2780/ADR and A2780/DDP), cancer cell lines and in primary ovarian cancer cells. Methods.: The effects of a small molecule mimic of Smac/DIABLO on ovarian cancer cell lines and primary ovarian cancer cells were determined by cell proliferation, apoptosis and biochemical assays. Results.: This compound added alone elicited only a weak proapoptotic effect; however, it strongly synergizes with tumor necrosis factor-related apoptosis inducing ligand (TRAIL) or agonistic TRAILR2 antibody (Lexatumumab) in inducing apoptosis of ovarian cancer cells. Conclusions.: These observations suggest that small molecule mimic of Smac/DIABLO could be useful for the development of experimental strategies aiming to treat ovarian cancer. Interestingly, in addition to its well known proapoptotic effects, Smac/DIABLO elicited a significant increase of pro-caspase-3 levels.

KW - Apoptosis

KW - Ovarian cancer

KW - Smac/DIABLO

KW - TRAIL

UR - http://www.scopus.com/inward/record.url?scp=34247163603&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247163603&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2007.01.011

DO - 10.1016/j.ygyno.2007.01.011

M3 - Article

C2 - 17292950

AN - SCOPUS:34247163603

VL - 105

SP - 481

EP - 492

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 2

ER -